#Japan #Toyama #STiV #Fanlead #Ikeda Mo-Han-Do

Ikeda Mo-Han-Do and its Journey with STiV

As the trusted manufacturer behind the well-known OTC product "Muhi," Ikeda Mo-Han-Do is set to celebrate the 100th anniversary of its iconic anti-itch medication in 2026. However, the company faced numerous operational challenges over the years, particularly related to information management and efficiency in its Reliability Assurance Department. With dated paper documents and fragmented systems, their reliance on veteran employees' memories led to inefficient workflows and challenges in accessing vital information swiftly.

In response to these pressing issues, Ikeda Mo-Han-Do has adopted an innovative knowledge management system named STiV, developed by its subsidiary, Fanlead. This AI-driven platform has played a pivotal role in transforming the company’s data management, significantly improving their operational efficiencies.

Key Achievements with STiV

1. Reduction in Information Retrieval Time:
By centralizing historic quality event data and external regulations, STiV has streamlined investigative tasks for the team. Employees can now access critical information much faster, drastically reducing the time needed for data retrieval.

2. Operational Efficiency Boost through OCR:
STiV employs Optical Character Recognition (OCR) technology to digitize handwritten factory documents instantly. This capability alone has halved the time required for report generation, cutting down from one hour of processing to just about 30 minutes. This efficiency not only saves time but also enhances the accuracy of documentation.

3. Advanced Cause Analysis through Generative AI:
In an experimental phase, the platform has been used for preliminary drafts of "5 Whys Analysis" based on deviation reports. Leveraging AI allows for multifaceted insights that might typically be missed by human analysts.

Insights from the Ikeda Mo-Han-Do Team

The Reliability Assurance Department at Ikeda Mo-Han-Do expressed satisfaction with STiV’s implementation. A representative commented, "Thanks to STiV, we can now utilize both paper and digital data in a unified manner. What stands out is not just the deployment, but the ongoing support provided during the Proof of Concept phase to enhance integration with our existing systems. We plan to expand our use of AI across all departments, potentially through internal hackathons to foster innovation."

Future Prospects

Fanlead aims to strengthen STiV’s integration with Ikeda Mo-Han-Do's existing systems and continue its evolution as a vital AI solution enhancing quality and reliability within the pharmaceutical industry. As STiV matures, it promises to further accelerate knowledge sharing and overcome production challenges, ensuring a resilient pharmaceutical workflow.

Conclusion

With the successful integration of STiV, Ikeda Mo-Han-Do is poised not only to celebrate a remarkable century of service with Muhi but also to position itself as a leader in embracing digital transformation within the healthcare sector. Tell us what you think of their journey and how AI can shape the future of pharmaceutical operations.

For more details, visit their case study and check out the STiV service site here.

Related Information

Ikeda Mo-Han-Do's endeavor to modernize illustrates a broader trend within the medical field, emphasizing the necessity for innovations to enhance productivity and information accessibility. As healthcare continues to evolve, companies that leverage AI will likely maintain a competitive edge, heralding a new era of operational excellence.